KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) Equity Ratio (2016 - 2026)

Bio-Rad Laboratories has reported Equity Ratio over the past 18 years, most recently at 0.7 for Q1 2026.

  • Quarterly Equity Ratio fell 96.77% to 0.7 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.7 through Mar 2026, down 96.77% year-over-year, with the annual reading at 0.7 for FY2025, 0.45% changed from the prior year.
  • Equity Ratio was 0.7 for Q1 2026 at Bio-Rad Laboratories, down from 0.7 in the prior quarter.
  • Over five years, Equity Ratio peaked at 29137.33 in Q4 2023 and troughed at 0.69 in Q3 2025.
  • The 5-year median for Equity Ratio is 0.71 (2022), against an average of 3014.87.
  • Year-over-year, Equity Ratio soared 24221.62% in 2022 and then tumbled 100.0% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 16025.33 in 2022, then soared by 81.82% to 29137.33 in 2023, then tumbled by 100.0% to 0.7 in 2024, then grew by 0.45% to 0.7 in 2025, then dropped by 0.7% to 0.7 in 2026.
  • Per Business Quant, the three most recent readings for BIO's Equity Ratio are 0.7 (Q1 2026), 0.7 (Q4 2025), and 0.69 (Q3 2025).